Lower lobe origin is a poor prognostic factor in locally advanced non-small-cell lung cancer patients treated with induction chemoradiotherapy

Author：                    

Publisher： Science Publishers

ISSN： 2049-9450

Source： Molecular and Clinical Oncology, Vol.3, Iss.3, 2015-01, pp. : 706-712

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Myelosuppression induced by concurrent chemoradiotherapy as a prognostic factor for patients with locally advanced non-small cell lung cancer

By                  

Oncology Letters, Vol. 2, Iss. 5, 2011-01 ,pp. : 949-955

Spandidos Publications

Access to resources Recommend Favorite

Use of chemo-radiotherapy in locally advanced non-small cell lung cancer

By Novello S.   Le Chevalier T.  

European Journal of Cancer, Vol. 38, Iss. 2, 2002-01 ,pp. : 292-299

Elsevier

Access to resources Recommend Favorite

Elevated serum levels of TPS and CYFRA 21-1 predict poor prognosis in advanced non-small-cell lung cancer patients treated with gefitinib

By Chen Fengsheng   Luo Xi   Zhang Jinbiao   Lu Yang   Luo Rongcheng  

Medical Oncology, Vol. 27, Iss. 3, 2010-09 ,pp. : 950-957

Humana Press, Inc

Access to resources Recommend Favorite

Effect of amifostine on toxicities associated with radiochemotherapy in patients with locally advanced non-small-cell lung cancer

By Antonadou D.   Throuvalas N.   Petridis A.   Bolanos N.   Sagriotis A.   Synodinou M.  

International Journal of Radiation Oncology*Biology*Physics, Vol. 57, Iss. 2, 2003-10 ,pp. : 402-408

Elsevier

Access to resources Recommend Favorite

High serum YKL-40 is a poor prognostic marker in patients with advanced non-small cell lung cancer

By Choi In Keun   Kim Yeul Hong   Kim Jun Suk   Seo Jae Hong  

Acta Oncologica, Vol. 49, Iss. 6, 2010-08 ,pp. : 861-864

Informa Healthcare

Access to resources Recommend Favorite